Literature DB >> 23271426

Cryoglobulinemic vasculitis in systemic sclerosis successfully treated with mycophenolate mofetil.

Predrag Ostojic1.   

Abstract

Cryoglobulinemic vasculitis is extremely rare in patients with systemic sclerosis (SSc). So far, only two cases of cryoglobulinemic vasculitis in SSc were described in the literature. This report is about a patient with SSc and secondary Sjőgren's syndrome, who developed typical clinical features of small-vessel vasculitis, including arthritis, purpura, microhaematuria, gangrene of fingers, and toes and myocardial ischemia, in the presence of mixed cryoglobulinemia, ANA, rheumatoid factor, and anti-SSA/Ro antibodies. Symptoms and signs of vasculitis worsened despite initial treatment with corticosteroids and cyclophosphamide, but improved significantly when mycophenolate mofetil was used instead cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271426     DOI: 10.1007/s00296-012-2640-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  10 in total

1.  Systemic sclerosis and cryoglobulinemia.

Authors:  J M Husson; P Druet; A Contet; J N Fiessinger; J P Camilleri
Journal:  Clin Immunol Immunopathol       Date:  1976-07

2.  Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

Authors:  Ellen M Ginzler; Mary Anne Dooley; Cynthia Aranow; Mimi Y Kim; Jill Buyon; Joan T Merrill; Michelle Petri; Gary S Gilkeson; Daniel J Wallace; Michael H Weisman; Gerald B Appel
Journal:  N Engl J Med       Date:  2005-11-24       Impact factor: 91.245

3.  Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?

Authors:  Maurizio Cutolo; Alberto Sulli; Vanessa Smith
Journal:  Expert Rev Clin Immunol       Date:  2011-07       Impact factor: 4.473

4.  A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.

Authors:  Melanie S Joy; Susan L Hogan; J Charles Jennette; Ronald J Falk; Patrick H Nachman
Journal:  Nephrol Dial Transplant       Date:  2005-09-27       Impact factor: 5.992

Review 5.  Mycophenolate mofetil in patients with hepatitis C virus infection.

Authors:  M Ramos-Casals; J Font
Journal:  Lupus       Date:  2005       Impact factor: 2.911

6.  Cryofibrinogenaemia: a study of 49 patients.

Authors:  H Blain; P Cacoub; L Musset; N Costedoat-Chalumeau; C Silberstein; O Chosidow; P Godeau; C Frances; J C Piette
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

7.  [CRST syndrome and mixed cryoglobulinemia (author's transl)].

Authors:  A Jiménez López; M A García Marcos; C Cañizo Fernández-Roldán; K Fuertes Martín; I Hernández Vicente; I Pastor Encinas
Journal:  Med Clin (Barc)       Date:  1980-01-10       Impact factor: 1.725

8.  Vasculitis in systemic sclerosis: association with Sjögren's syndrome and the CREST syndrome variant.

Authors:  C V Oddis; C H Eisenbeis; H E Reidbord; V D Steen; T A Medsger
Journal:  J Rheumatol       Date:  1987-10       Impact factor: 4.666

9.  Cryofibrinogenaemia and acute gangrene in systemic sclerosis.

Authors:  M C Barrett; J S Prendiville; B J Pardy; J J Cream
Journal:  Postgrad Med J       Date:  1986-10       Impact factor: 2.401

Review 10.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

  10 in total
  4 in total

Review 1.  [Leg discoloration].

Authors:  L Unger; U Wollina; J Machetanz; C Stelzner; S Schellong
Journal:  Internist (Berl)       Date:  2013-11       Impact factor: 0.743

2.  Vasculitis with renal involvement in essential mixed cryoglobulinemia: Case report and mini-review.

Authors:  Sabiha Anis; Khawar Abbas; Mohammad Mubarak; Ejaz Ahmed; Sajid Bhatti; Rana Muzaffar
Journal:  World J Clin Cases       Date:  2014-05-16       Impact factor: 1.337

Review 3.  Connective Tissue Disorder-Associated Vasculitis.

Authors:  Aman Sharma; Aadhaar Dhooria; Ashish Aggarwal; Manish Rathi; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 4.  Managing refractory cryoglobulinemic vasculitis: challenges and solutions.

Authors:  Predrag Ostojic; Ivan R Jeremic
Journal:  J Inflamm Res       Date:  2017-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.